SINOVAC BIOTECH LTD. - Common Shares, par value US$0.001 per share (SVA)

CUSIP: P8696W104

Q2 2014 13F Holders as of 30 Jun 2014

Type / Class
Equity / Common Shares, par value US$0.001 per share
Shares outstanding
71,872,133
Total 13F shares
13,183,464
Share change
-1,292,834
Total reported value
$74,347,660
Put/Call ratio
488%
Price per share
$5.64
Number of holders
50
Value change
-$7,915,266
Number of buys
19
Number of sells
26

Sponsored

Quarterly Holders Quick Answers

What is CUSIP P8696W104?
CUSIP P8696W104 identifies SVA - SINOVAC BIOTECH LTD. - Common Shares, par value US$0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of SVA - SINOVAC BIOTECH LTD. - Common Shares, par value US$0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
WELLINGTON MANAGEMENT GROUP LLP
13F
Company
7.1%
5,120,943
$36,871,000 31 Mar 2014
13F
ORBIMED ADVISORS LLC
13F
Company
2.3%
1,637,500
$11,790,000 31 Mar 2014
13F
DAVIS SELECTED ADVISERS
13F
Company
1.7%
1,244,206
$8,958,000 31 Mar 2014
13F
FIL Ltd
13F
Company
1.5%
1,069,500
$7,700,000 31 Mar 2014
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
1.4%
1,031,711
$7,428,000 31 Mar 2014
13F
Visium Asset Management, LP
13F
Company
1.4%
1,000,000
$7,200,000 31 Mar 2014
13F
BlackRock Fund Advisors
13F
Company
0.94%
677,179
$4,876,000 31 Mar 2014
13F
PICTET ASSET MANAGEMENT LTD
13F
Company
0.68%
488,100
$3,514,000 31 Mar 2014
13F
JANE STREET GROUP, LLC
13F
Company
0.31%
222,323
$1,601,000 31 Mar 2014
13F
BOGLE INVESTMENT MANAGEMENT L P /DE/
13F
Company
0.27%
197,057
$1,418,000 31 Mar 2014
13F
Invesco Ltd.
13F
Company
0.25%
180,452
$1,299,000 31 Mar 2014
13F
TWO SIGMA INVESTMENTS, LP
13F
Company
0.22%
158,613
$1,142,000 31 Mar 2014
13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM
13F
Company
0.22%
158,903
$1,050,000 31 Mar 2014
13F
DEUTSCHE BANK AG\
13F
Company
0.19%
135,876
$977,000 31 Mar 2014
13F
CITADEL ADVISORS LLC
13F
Company
0.18%
128,577
$926,000 31 Mar 2014
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.15%
106,953
$770,000 31 Mar 2014
13F
A.R.T. Advisors, LLC
13F
Company
0.13%
94,832
$682,000 31 Mar 2014
13F
TWO SIGMA ADVISERS, LP
13F
Company
0.12%
87,300
$630,000 31 Mar 2014
13F
Pine River Capital Management L.P.
13F
Company
0.09%
65,484
$471,000 31 Mar 2014
13F
WEXFORD CAPITAL LP
13F
Company
0.08%
56,000
$403,000 31 Mar 2014
13F
CREDIT SUISSE AG/
13F
Company
0.07%
48,244
$347,000 31 Mar 2014
13F
Virtu KCG Holdings LLC
13F
Company
0.07%
47,676
$343,000 31 Mar 2014
13F
HighTower Advisors, LLC
13F
Company
0.06%
45,925
$331,000 31 Mar 2014
13F
TFS CAPITAL LLC
13F
Company
0.06%
43,059
$310,000 31 Mar 2014
13F
ELLINGTON MANAGEMENT GROUP LLC
13F
Company
0.06%
43,000
$310,000 31 Mar 2014
13F
ProShare Advisors LLC
13F
Company
0.06%
42,409
$305,000 31 Mar 2014
13F
MORGAN STANLEY
13F
Company
0.04%
29,274
$210,000 31 Mar 2014
13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP
13F
Company
0.04%
28,364
$204,000 31 Mar 2014
13F
COMMONWEALTH BANK OF AUSTRALIA
13F
Company
0.04%
28,033
$202,000 31 Mar 2014
13F
GROUP ONE TRADING LLC
13F
Company
0.04%
25,252
$182,000 31 Mar 2014
13F
ClariVest Asset Management LLC
13F
Company
0.04%
25,200
$181,000 31 Mar 2014
13F
ARDSLEY ADVISORY PARTNERS LP
13F
Company
0.03%
25,000
$180,000 31 Mar 2014
13F
NAVELLIER & ASSOCIATES INC
13F
Company
0.03%
24,800
$179,000 31 Mar 2014
13F
BlackRock Institutional Trust Company, N.A.
13F
Company
0.03%
24,208
$174,000 31 Mar 2014
13F
WESTPORT RESOURCES MANAGEMENT INC
13F
Company
0.03%
22,925
$165,000 31 Mar 2014
13F
B. Riley Wealth Advisors, Inc.
13F
Company
0.03%
22,295
$161,000 31 Mar 2014
13F
PRELUDE CAPITAL MANAGEMENT, LLC
13F
Company
0.02%
17,700
$127,000 31 Mar 2014
13F
CITIGROUP INC
13F
Company
0.02%
15,715
$113,000 31 Mar 2014
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.02%
11,588
$83,000 31 Mar 2014
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.01%
10,722
$77,000 31 Mar 2014
13F
BARCLAYS PLC
13F
Company
0.01%
9,173
$64,000 31 Mar 2014
13F
AMERICAN INTERNATIONAL GROUP, INC.
13F
Company
0.01%
5,500
$39,600 31 Mar 2014
13F
UBS AG
13F
Company
0.01%
5,389
$39,000 31 Mar 2014
13F
BANK OF MONTREAL /CAN/
13F
Company
0.01%
4,400
$32,000 31 Mar 2014
13F
Tower Research Capital LLC (TRC)
13F
Company
0%
3,490
$25,000 31 Mar 2014
13F
BANK OF AMERICA CORP /DE/
13F
Company
0%
2,021
$15,000 31 Mar 2014
13F
Creative Planning
13F
Company
0%
1,000
$7,000 31 Mar 2014
13F
MSI Financial Services Inc
13F
Company
0%
1,000
$7,000 31 Mar 2014
13F
WELLS FARGO & COMPANY/MN
13F
Company
0%
750
$5,000 31 Mar 2014
13F
Apriem Advisors
13F
Company
0%
300
$2,000 31 Mar 2014
13F

Institutional Holders of SINOVAC BIOTECH LTD. - Common Shares, par value US$0.001 per share (SVA) as of Q2 2014

As of 30 Jun 2014, SINOVAC BIOTECH LTD. - Common Shares, par value US$0.001 per share (SVA) was held by 50 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 13,183,464 shares. The largest 10 holders included WELLINGTON MANAGEMENT CO LLP, ORBIMED ADVISORS LLC, DAVIS SELECTED ADVISERS, RENAISSANCE TECHNOLOGIES LLC, Visium Asset Management, LP, FIL Ltd, BlackRock Fund Advisors, PICTET ASSET MANAGEMENT LTD, Pine River Capital Management L.P., and Invesco Ltd.. This page lists 50 institutional shareholders reporting positions in this security for the Q2 2014 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q2 2014 vs Q1 2014 Across Filers

Q1 2014 holders
51
Q2 2014 holders
50
Holder diff
-1
Investor Q1 2014 Shares Q2 2014 Shares Share Diff Share Chg % Q1 2014 Value $ Q2 2014 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.